Manual on the proper use of meta-[<sup>211</sup>At] astato-benzylguanidine ([<sup>211</sup>At] MABG) injections in clinical trials for targeted alpha therapy (1st edition).

Authors:
Ukon N; Higashi T; Hosono M; Kinuya S; Yamada T and 3 more

Journal:
Ann Nucl Med

Publication Year: 2022

DOI:
10.1007/s12149-022-01765-1

PMCID:
PMC9304041

PMID:
35794455

Journal Information

Full Title: Ann Nucl Med

Abbreviation: Ann Nucl Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Nuclear Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflict of interestThe authors have no conflicts of interest to declare. Conflict of interest The authors have no conflicts of interest to declare."

Evidence found in paper:

"Funding Funding was provided by the Ministry of Health, Labour and Welfare, Japan (Grant No. 19IA1004)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025